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THE AETIOLOCY of Hodgkin's disease {HD) is 
still unknown. However, several epidemiologi- 
cal studies have postulated an association be- 
tween HD and preceding infectious mononuc- 
leosis (IM) [1, 2]. The causative agent in IM 
is the Epstein-Barr virus ¢EBV) [3]. Although 
in many cases of HD serum titers against EBV 
are somewhat increased [4, 5], some cases of 
HD show no antibody evidence of EBV in- 
fection. Serious doubts as to any specific role 
for EBV in HD come from cases with estab- 
lished HD in which IM occurred during the 
course of the disease [6, 7]. 
The purpose of this communication is to 
show by DNA analysis of the tumor cells-- 
searching for EBV genomes--that, although 
HI) developed shortly alter IM and antibody 
response to EBV was compatible with the 
convalescent phase of IM, EB-viral infection 
most likely may not be directly oncogenic but 
rather may contribute to an immunologic 
state which in turn predisposes to malignancy. 
CASE REPORT 
In November 1979, a 21-yr-old male pa- 
tient noticed a painless lymph node swelling 
of the right side of his neck with a concom- 
itant swollen right tonsil. Otherwise he felt 
well and had no signs of malaise, weight loss 
or night sweats. About six weeks prior, he 
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remembered having symptoms of a common 
cold. On 21 December, a lymph node biopsy 
was done revealing an unspecific, chronic 
inflammation compatible with a viral infec- 
tion. In January 1980, IM was suspected 
because of a slightly positive Paul-Bunnel test 
for heterophil antibodies tl :16) as well as 
positive titers of specific IgM and IgG anti- 
bodies {1:16 vs 1:64) against EBV viral cap- 
sid antigen {VCA). The WBC at that time 
was 5 x 109/1 with a differential of 57°'i, neut- 
rophils, 5% eosinophils, 1'I'o basophils, 10°o 
monocytes and 27°'o lyinphocytes. Three 
weeks later, the Paul-Bunnel test and EBV- 
VCA IgM antibodies had become negative, 
EBV-VCA IgG-(1:128), early antigen tEA)- 
tl : 10) and Epstein-Barr virus nuclear antigen 
{EBNA)-antibody titers were positive. Within 
another three weeks EBV-EA antibodies be- 
came negative too. 
Since the patient felt no improvement of his 
swellings, particularly of his right tonsil, he 
had the latter removed in the end of 
February. Histological examination showed an 
identical picture to that of the lymph node 
biopsy performed one month earlier. 
Therefore, no treatment was initiated. Because 
of the persistent cervical lymph node enlarge- 
ment involving the right anterior triangle, the 
patient was transferred to our hospital. He 
was otherwise well and physical examination 
revealed no other abnormalities. X-ray of the 
chest and thoracic inlet were normal. Routine 
laboratory tests were within normal range 
{ESR, sodium, potassium, serum electro- 
phoresis, transaminases, alkaline phosphatase, 
peripheral blood--except for 8<~0 atypical mo- 
nonuclear cells in the differential count). The 
IM slide screening test {Monospot) was ne- 
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gative as were EBV-VCA IgM, EBV-EA and 
heterophil antibody titers. EBV-VCA IgG 
(1:256) and EBNA were still positive. 
Antibody titers to adeno-, cytomegaly- and 
mumps virus were negative. 
Finally, on 13 April another large lymph 
node biopsy from the same region was pertor- 
med, mainly in an attempt o search for EBV 
genomes in the persistent lymph node tumor. 
Employing several sensitive methods for de- 
tection of EBV-DNA sequences, no EB viral 
genomes were found in the tumor cells: 
Reassociation kinetics with tumor cell DNA 
using in vitro 3H-labelled EBV-DNA should 
have allowed the detection of one EBV ge- 
nome per ten cells [8]. In addition, in situ 
hybridization with frozen sections of the biop- 
sy was performed using 3H-labelled EBV- 
DNA as in the reassociation kinetics, a pro- 
cedure similar to that employed for detection 
of EBV-DNA in nasopharyngeal carcinoma 
[9]. This method should have allowed the 
detection of a few cells carrying EBV genomes 
scattered in the tissue, even though the ave- 
rage number of EBV genomes per total biopsy 
cells would not have permitted their detection 
by reassociation kinetics. EBNA, another im- 
portant viral marker, could not be dem- 
onstrated within the tumor cells by immuno- 
fluorescence technique [10] examining more 
than 1000 cells. 
However, on morphological examination, 
the diagnosis of a lymphogranulomatosis from 
the epitheloid cell type was established. 
According to the Kiel classification, this is a 
rare entity with poor prognosis and an abun- 
dance of epitheloid and Reed-Sternberg cells 
[11]. Staging procedures including explo- 
ratory laparotomy and splenectomy revealed a
stage I A according to the Ann Arber criteria. 
Therefore, radiotherapy was initiated. 
DISCUSSION 
This case is remarkable for several reasons. 
HD developed during the late convalescent 
phase of IM as documented by serial his- 
tological examinations of involved lymph 
nodes and rising and falling EBV antibody 
titers. Although from a clinical point of view 
the correlation between IM and subsequent 
HD seems to be quite obvious, it does not 
necessarily imply that EB virus is oncogenic. 
As in the African Burkitt's lymphoma or in 
the nasopharyngeal carcinoma, a prerequisite 
for this possibility would be the presence of 
viral footprints within the tumor cells. Despite 
an extensive search in a large tumor mass 
using very sensitive methods, neither EBV 
DNA nor EBNA could be detected. 
On the other hand, the typical pattern of 
IM heterophil and EBV antibody establish 
beyond doubt the diagnosis of preceding IM 
in our patient, whose clinical symptoms might 
have been uncharacteristic at the time of 
presentation. The most specific and sensitive 
marker for IM is the detection of antibodies 
against he EBV-VCA. The specific IgM anti- 
bodies are valuable early diagnostic tools, 
since their presence denotes in all probability 
a current primary infection [12]. VCA-IgG 
antibodies appear within five to seven days of 
infection and remain positive for life [13]. The 
measurement of this antibody is usually of no 
help in determining the diagnosis of initial 
infection unless one is able--as in our case-- 
to catch that fleeting point of a rise in 
serological titer. EBV-EA antibodies have 
proven to be of considerable diagnostic value, 
since appearance of this antibody is transitory 
in IM and practically never seen in healthy 
donors [12]. Taking the complete serological 
pattern of our patient into account (Fig. 1) 
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Fig. 1. Schematic presentation of antibody ~*sponses to 
Epstein-Barr virus. The normal values in our laboratory jbr a 
normal population are: anti-VCA-IgM, 1:4; anti-VCA-IgG, 
1 : 64; anti-EA, 1 : 8; H.A., 1 : 4. Values above these titers are 
considered positive; however, the complete pattern oJ antibody 
titers has to be taken into account for the diagnosis of lM. H.A. 
= heterophil antibody. The arrows indkate the serial histological 
examinations. 
together with a history of a "common cold" 
during the month of October, one could 
pinpoint the stage of IM at first presentation 
as being in the late convalescent phase. 
An association between IM and the de- 
velopment of certain lymphoproliferative dis- 
eases has been postulated [14] and supported 
by several seroepidemiological studies [1, 13]. 
Limitations of most of these studies are that 
they are too small to be interpreted with 
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confidence and that the diagnosis of IM  was 
not well documented. One study in which 
both limitations were overcome [2] shows a 
tbur-fold increase in rate of HD among people 
who had IM. The excess risk was greatest 
within three years of diagnosis of IM. A 
possible explanation for their association is 
that IM and HD might have a common cause 
such as an immune deficiency state. Another 
alternative is that IM may promote the rapid 
development of HD in a person in whom the 
disease is latent or progressing slowly. The 
point of this report is to show using sensitive 
microbiological tests that there seems to be no 
direct oncogenic relationship between EBV 
and HD, because no EB viral marker could 
be identified in the tumor cells. This situation 
contrasts markedly to the one described for 
Burkitt's lymphoma and nasopharyngeal car- 
cinoma, although in either case, EB virus 
might well be an important risk factor in the 
development of malignant diseases. 
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